Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients

Keyphrases

• Acute Myeloid Leukemia 100%
• Annualized Relapse Rate 14%
• CD34+ Cells 14%
• Cell Maturation 14%
• Cell Proliferation 14%
• De Novo Acute Myeloid Leukemia 14%
• Disease-free Survival 14%
• Expression Analysis 14%
• Human Malignancies 14%
• Intermediate Risk 14%
• Leukemia Patients 100%
• Low Expression 14%
• MicroRNA-29 14%
• MiR-30a 100%
• MiR-30b 14%
• Multivariate Analysis 14%
• MYBL2 100%
• Overexpression 100%
• Poor Prognosis 14%
• Prognostic Value 100%
• Transcription Factor 14%
• Tumorigenesis 14%

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Cancer 50%
• Carcinogenesis 50%
• Cell Maturation 50%
• Cell Proliferation 50%
• Cumulative Incidence 50%
• De Novo Acute Myeloid Leukemia 50%
• Disease Free Survival 50%
• Expression Analysis 50%
• Karyotype 50%
• microRNA 100%
• microRNA 29 50%
• Multivariate Analysis 50%
• Transcription Factors 50%

Immunology and Microbiology

• CD34 33%
• Cell Maturation 33%
• Cell Proliferation 33%
• Disease Free Survival 33%
• Expression Analysis 33%
• Karyotype 33%
• Myeloid 100%
• Transcription Factors 33%